Connection
Kevin Lillehei to Neoplasms
This is a "connection" page, showing publications Kevin Lillehei has written about Neoplasms.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.267 |
|
|
|
-
Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses. 2000 Jul; 55(1):29-35.
Score: 0.069
-
Lillehei KO, Liu Y, Kong Q. Current perspectives in immunotherapy. Ann Thorac Surg. 1999 Sep; 68(3 Suppl):S28-33.
Score: 0.065
-
Kong Q, Lillehei KO. Antioxidant inhibitors for cancer therapy. Med Hypotheses. 1998 Nov; 51(5):405-9.
Score: 0.061
-
Mayer-Sonnenfeld T, Har-Noy M, Lillehei KO, Graner MW. Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure. Int J Hyperthermia. 2013 Sep; 29(6):520-7.
Score: 0.042
-
Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features. Acta Neuropathol. 2008 Sep; 116(3):289-301.
Score: 0.030